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Malaria in pregnancy predisposes to maternal anemia and low birth weight (LBW). We examined the
possible roles of the cytokines tumor necrosis factor alpha (TNF-) and gamma interferon (IFN-) in these
adverse outcomes. We measured cytokine concentrations in placental, peripheral, and cord blood plasma in
relation to malaria parasitemia and placental monocyte accumulation in 276 Malawian women. Maternal
hemoglobin concentration, human immunodeficiency virus status, and infant birth weight were determined.
Concentrations of TNF- in placental blood were correlated with densities of Plasmodium falciparum-infected
erythrocytes (P < 0.0001) and of intervillous monocyte infiltrates (P < 0.0001) on placental histology.
Peripheral blood TNF- concentrations were relatively low and were weakly associated with malaria. TNF-
concentrations were higher in placental blood, where they were strongly associated with malaria. Placental
plasma TNF- levels were higher in women who had LBW babies (P  0.0027), women with febrile symptoms
(P < 0.0001), and teenage mothers (P  0.04) than in other women. The presence of TNF- in cord blood was
not associated with malaria infection. IFN- levels were infrequently elevated, and elevated IFN- levels were
not associated with poor pregnancy outcomes. Placental production of TNF-, but not of IFN-, may be
implicated in impaired fetal growth in Malawian women.
Malaria in pregnancy can have adverse consequences for
both mother and infant. Malaria increases the risk of anemia in
pregnant women and is the single most important preventable
cause of low birth weight (LBW), which is associated with high
infant mortality (28). The mechanisms by which malaria exerts
these adverse effects are poorly understood. Placental infection
with Plasmodium falciparum may be accompanied by mononu-
clear cell infiltrates (3, 30). Dense monocytic infiltrates within
the intervillous space are not infrequent in malaria infection
and are rare in the absence of malaria (19). These infiltrates
are associated with intrauterine growth retardation in malaria-
exposed pregnancies (12). Recently, we have found that the
presence of malaria pigment-containing fibrin or leukocytes
and the numbers of placental monocytes independently predict
low infant birth weight and low maternal hemoglobin (23a).
In normal human pregnancy, a placental bias toward T
helper 2 (Th2) responses (13) may be important for successful
pregnancy (21). In placental malaria infection, a proinflamma-
tory or Th1 cytokine response appears common. Cytokines
associated with placental malaria have been measured by a
number of techniques, including assays of placental serum (8,
9), RNase protection assay (18), and secretion in vitro by
placental blood cells, purified mononuclear cells, or villous
explants (5, 8, 16, 17). Malaria-associated increases in tumor
necrosis factor alpha (TNF-), interleukin 8 (IL-8), gamma
interferon (IFN-), IL-6, and IL-10 have been reported in one
or more assay systems, but only increased placental TNF-
levels have been repeatedly associated with LBW (9, 18).
To further investigate associations between malaria, mater-
nal anemia, and LBW, we have quantified leukocytes and par-
asitized erythrocytes within the placental intervillous space and
measured concentrations of the cytokines TNF- and IFN- in
placental, peripheral, and cord plasma. We have examined the
influence of human immunodeficiency virus (HIV) infection in
this process and used multivariate analysis to determine
whether TNF- concentrations are associated with poor preg-
nancy outcomes, independently of placental parasitemia.
MATERIALS AND METHODS
Women attending Queen Elizabeth Central Hospital, Blantyre, Malawi, for
delivery were screened for malaria infection by examination of thick films from
placental and peripheral blood. Giemsa-stained films were examined by counting
parasites against 200 leukocytes, and parasitemia was determined by using an
assumed leukocyte count of 6,000/l. Women with malaria infection (peripheral
and/or placental parasitemia of 1,000/l on thick-film microscopy) and unin-
fected controls (matched for gravidity and for age within 2 years, but with periph-
eral and placental thick blood films negative for malaria) were recruited into the
study following witnessed informed consent. A placental parasite density of
1,000/l was seen in 77.5% of infected women in this study, but in only 48.9% of
infected women delivering in the hospital (S. J. Rogerson, E. Chaluluka, L.
Njiragoma, M. Kanjala, P. Mkundika, and M. E. Molyneux, unpublished data).
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Blood films were examined by a second microscopist, with a third read to
resolve conflicting results, as described elsewhere (23). Final parasitemia was the
average of two agreeing counts. Babies were weighed at delivery; LBW was
defined as 2,500 g.
Venous blood was collected from a peripheral vein and cord blood was col-
lected from umbilical veins by venipuncture. Placental blood was collected by
incising the maternal surface of the placenta (which was cleaned with sterile
gauze and normal saline) and aspirating blood welling into the incision with a
sterile transfer pipette. Heparinized (first 40 cases) or EDTA plasma was sepa-
rated within an hour of delivery and frozen at 70°C until it was aliquoted for
assay. Placental tissue biopsy specimens (2 by 2 by 1 cm) were collected into
neutral buffered formalin. After fixation, blocks were wax embedded, and sec-
tions stained with Giemsa stain or hematoxylin and eosin were prepared by
standard procedures. Maternal hemoglobin concentrations were measured with
a Hemocue (Angelholm, Sweden) hemoglobinometer.
Placental tissue examination. Placental sections were examined by a standard-
ized approach, and parasite and monocyte densities were determined by count-
ing 500 intervillous-space cells, including infected and uninfected erythrocytes
and leukocytes (23a). Parasitemia was expressed as the number of infected
erythrocytes per total number of erythrocytes. Monocyte density was calculated
as the number of monocytes detected per total erythrocytes and leukocytes
counted. Each was expressed as a percentage. Malaria pigment (hemozoin) in
monocytes and in fibrin was assessed by using a semiquantitative scale (score, 0
to 4) and recorded as present or absent.
HIV testing. For the first 120 samples, HIV testing was performed on coded
samples, without patient identifiers. For subsequent samples, HIV testing fol-
lowed voluntary counselling and testing, performed the day after delivery.
Plasma or serum was tested by a Serocard rapid test for HIV types 1 and 2
(HIV-1 and -2) (Trinity Biotech, Dublin, Ireland), and results were confirmed by
either HIV-1 and -2 ELISA (Ortho-Clinical Diagnostics, Neckargemund, Ger-
many), Vironostika HIV Uni-Form II (Organon Teknika, Boxtel, The Nether-
lands), or Determine (Abbott Laboratories, Amadora, Portugal).
Cytokines. Cytokine assays were performed on consecutive placental plasma
samples available from women enrolled in the study. Placental and maternal or
cord blood cytokine concentrations were measured for TNF- and IFN- by
using enzyme-linked immunosorbent assay kits from R&D Systems, Abingdon,
United Kingdom, according to the manufacturer’s instructions. Additional cord
blood samples were assayed for TNF- by using the human TNF- Duoset
(R&D Systems, Minneapolis, Minn.). Only samples collected into EDTA were
analyzed for IFN-. Limited peripheral blood samples were assayed owing to
lack of reagents. For TNF-, assays were performed on peripheral, placental,
and cord blood samples from 20, 241, and 141 individuals, respectively. For
IFN- the numbers were 32, 187, and 53 samples. From information supplied by
the manufacturer, the upper limits of normal were defined as 15.6 pg/ml for both
IFN- and TNF-.
Statistical analysis. Data were entered into Microsoft Access and transferred
to Stata 6.0 (Stata Corp., College Station, Tex.) for analysis. Normally distributed
data were compared by Student’s t test, and nonnormally distributed data were
compared by the Wilcoxon rank sum test.
Ethical approval. The studies were approved by the College of Medicine
Research Committee, University of Malawi.
RESULTS
Of 276 women in the study, placental histology was available
for 254. By histology, 102 (40%) were uninfected; of these, 3
had parasitemia on placental film only and 2 had parasitemia
on maternal film only. One hundred fifty-two women (60%)
had parasites on placental histology. Of these, 85 were positive
on peripheral and placental blood films, 14 were positive on
placental but not maternal blood film, and 53 were negative on
both blood films. A further 43 women (17%) had fibrin pigment
but no parasites on histology, indicative of previous infection.
Fifty-eight percent of women with malaria had experienced
febrile symptoms in the previous week, compared to 18.8% of
women without malaria (odds ratio [OR], 6.1; 95% confidence
interval [95% CI], 3.3 to 11.1; P  0.001). Birth weights and
maternal hemoglobin concentrations were compared between
women with and without malaria on peripheral or placental
blood film or placental histology. Birth weights differed most
significantly between women with and without peripheral par-
asitemia (2.65  0.51 kg compared to 2.90  0.47 kg; P 	
0.0001) and least between women with and without malaria on
placental histology (2.77 0.50 kg compared to 2.89 0.52 kg;
P 	 0.056). Mean hemoglobin concentrations were 11.1  1.8
g/dl for women with malaria on histology and 12.0  1.9 g/dl
for women without active infection (P 	 0.0003). Differences
in hemoglobin levels were similar however malaria was defined
(P  0.002 for each comparison).
Levels of TNF- were higher in placental than in peripheral
or cord blood and were higher in infected than in uninfected
placentas (Table 1). Differences in placental (P  0.0001) and
peripheral (P  0.05) blood levels were similar if malaria was
categorized on the basis of peripheral or placental parasitemia
rather than histology. High concentrations of TNF- in pla-
cental plasma (15.6 pg/ml) were detected in 66 women with
placental histology available, 53 of whom (80.3%) had malaria
infection (OR, 3.9; 95% CI, 2.0 to 7.7; P  0.001). Placental
TNF- levels were correlated with placental parasitemia (r 	
0.40; P  0.0001) and density of placental monocytic infiltrates
(r 	 0.39; P  0.0001). Placental TNF- concentrations were
significantly higher in LBW babies (median, 11.6 pg/ml) than
in babies weighing 2,500g (median, 5.6 pg/ml; P 	 0.0045)
(Table 2). The relationship between malaria and TNF- was
independent of gravidity. TNF- levels correlated with placen-
tal parasitemia in primigravidae (r2 	 0.42; P  0.0001) and
women in their second or later pregnancy (r2 	 0.35; P 	
0.0001). After stepwise regression, placental parasitemia on
histology (P 	 0.031), gravidity (P 	 0.003), and maternal
hemoglobin (P 	 0.007) were significantly associated with in-
fant birth weight, whereas TNF- was not (P 	 0.26).
Cord blood TNF- concentrations were not associated with
the presence or density of placental malaria infection (Table 1)
or with infant birth weight (r2 	 0.04; P 	 0.59). Placental and
cord blood TNF- concentrations were not correlated (r2 	
0.03; P	 0.74). Cord blood parasitemia was infrequent and low
density (2.9%; maximum density, 150/l). We did not have ges-
tational assessments or postdelivery information on these babies.
IFN- levels were low in placental plasma but were slightly
higher in 114 women with placental malaria (median, 0.7 pg/
ml; interquartile range, 0 to 6.1 pg/ml) than in 73 uninfected
women (median, 0; interquartile range, 0 to 0.57 pg/ml; P 	
0.0001). IFN- levels were increased in only eight placental
samples (4%), five with and three without malaria. IFN- was
not detectable in 24 of 32 peripheral blood and 51 of 53 cord
blood samples and was never elevated in these samples. IFN-
levels were significantly higher in HIV-infected than in unin-
fected women without placental malaria (0.7 pg/ml [interquar-
TABLE 1. TNF- concentrations in placental, peripheral, and cord
blood in relation to malaria infection of the placenta
Blood
Median TNF- concn (interquartile range); no.
of samples tested P
(rank sum)
Malaria No malaria
Placental 10.0 (4.0–24.0); 142 3.3 (1.0–8.3); 99 0.0001
Peripheral 2.9 (1.63–6.4); 14 0.47 (0.18–0.96); 8 0.026
Cord 7.9 (0–19.0); 86 2.5 (0–16.2); 55 0.87
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tile range, 0 to 6.1 pg/ml] compared to 0 [interquartile range,
0 to 0.6 pg/ml]; P 	 0.025).
Table 2 compares placental TNF- concentrations accord-
ing to maternal characteristics and LBW. Young maternal age,
recent febrile symptoms, and LBW infants were associated
with increased placental TNF- levels. Women with febrile
symptoms, but without malaria, did not have increased placen-
tal TNF- concentrations. HIV infection was not associated
with TNF- concentrations, nor was peripheral, placental, or
histological parasitemia higher in HIV-infected than in unin-
fected women (P  0.38 for all comparisons).
DISCUSSION
TNF- is expressed in normal placentas by trophoblast cells
and by cells thought to be macrophages (22), and it appears to
play a role in term and preterm labor (reviewed in reference 1).
Placental overproduction of TNF- and other proinflamma-
tory cytokines may be important in the development of pre-
eclampsia, possibly in response to hypoxia (6), and has been
implicated in the pathogenesis of intrauterine growth retarda-
tion (11), possibly by decreasing amino acid uptake by the fetus
(4). Lipopolysaccharide may stimulate TNF- production,
leading to abortion in mice (26). Malarial glycosylphosphati-
dylinositol has lipopolysaccharide-like effects (25) and stimu-
lates monocyte TNF- release.
We measured placental, peripheral, and cord plasma TNF-
and IFN- levels and related them to the densities of placental
malaria infection and monocyte infiltrates and to maternal
hemoglobin and infant birth weight. Malaria-associated in-
creases were largely confined to the placenta. Placental TNF-
levels were more commonly elevated in women who had pla-
cental malaria, who had recent febrile symptoms, or who gave
birth to LBW babies. IFN- was usually detected only in low
concentrations and was not associated with malaria or adverse
pregnancy outcomes. Moormann et al. (18) found increased
mRNA expression of TNF- in placental tissues of Malawian
women, findings similar to the changes in placental plasma
protein levels that we detected. Our data confirm that the
placenta is the likely site for production of TNF-. Similar
findings have been reported for women from Kenya and Cam-
eroon (8, 9). In each case, levels of TNF- were higher than
those we detected, and serum (not plasma) was used for mea-
surements.
Placental parasite densities were similar in women of differ-
ent gravidity, and the placental TNF- response to malaria did
not differ according to gravidity. Gravidity-based differences in
cytokine responses to malaria have been proposed (16) to
explain the difference in susceptibility to malaria between pri-
migravid and multigravid women (27), but our data do not
support such a phenomenon in this population. Instead, hu-
moral immune responses may be more important (2).
In malaria-infected placentas, TNF- is produced princi-
pally by monocytes and macrophages (18), and intervillous
monocyte infiltrates are associated with LBW in multivariate
analyses (15, 23a). Placental malaria may exert some of its
adverse effects on mother and child by triggering monocytic
infiltration and local TNF- production. Multivariate analysis
(not previously applied to studies of cytokines in placental
malaria) did not confirm an independent role for TNF- in the
pathogenesis of LBW. The short half-life of cytokines com-
pared to the slow pace of changes in hemoglobin concentration or
malaria parasitemia may militate against such findings. Alterna-
tively, increased TNF- levels may be a marker, rather than a
mediator, of LBW. Only animal studies can resolve this issue.
Cord TNF- concentrations were not associated with ma-
laria infection at delivery. Increased cord TNF- concentra-
tions have been found in association with neonatal sepsis (24)
and in premature infants were associated with cerebral lesions
on magnetic resonance imaging (7). While some infants had
high cord TNF- concentrations, our study suggests that LBW
associated with malaria is more likely due to changes such as
TNF- production at the level of the placenta. Placental and
cord TNF- levels were not associated, suggesting that passage
of cytokines into cord blood is not a likely mechanism of
TNF- action.
We found strong associations between monocyte densities,
malaria infection, febrile symptoms, and TNF- concentra-
tions, even though we were not able to exclude other infec-
tions, and we measured placental monocyte counts and cyto-
kine concentrations only at delivery (Table 2). Women with
fever and without placental malaria infection did not have
elevated placental cytokine concentrations. Maternal febrile
symptoms were associated with the presence of malaria, par-
asite densities, and cytokine levels (Table 2), suggesting that
malaria infection caused a significant component of the febrile
symptoms in this group.
Women with low-density infections had neither poor out-
comes nor placental monocyte infiltrates, and they had lower
cytokine levels than women with denser infections. Women in
the more heavily infected group were at significantly higher
risk of adverse pregnancy outcomes. There may be a threshold
of infection density above which monocyte infiltrates and in-
flammatory responses occur.
Differences in placental IFN- responses to malaria infec-
TABLE 2. Patient characteristics and placental TNF- concentrations
Patient characteristica
Median placental TNF- concn (interquartile range); no. of samples
Pb
Factor present Factor absent
Teenager 8.2 (3.1–18.6); 94 5.6 (2.1–14.6); 166 0.04
Primigravid 6.9 (2.2–18.2); 136 5.6 (2.7–12.3); 123 0.27
Recent febrile symptoms 11.0 (4.6–26.0); 104 4.0 (1.7–9.7); 147 0.0001
Anemic (Hb, 11 g/dl) 7.3 (2.9–19.6); 86 6.1 (2.7–15.8); 156 0.26
HIV infected 7.1 (2.8–18.6); 105 5.3 (2.1–14.2); 149 0.20
LBW 11.6 (4.6–24.9); 48 5.5 (2.1–12.3); 207 0.0045
a Hb, hemoglobin.
b Compared by the Wilcoxon rank sum test.
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tion between different African regions are intriguing. Two
groups in Kenya have reported roles for IFN- in malaria-
exposed pregnancies. Detectable IFN- levels (10 pg/ml)
were found in about 40% of placental plasma samples from
Kenyan women and were associated in certain patient groups
with malaria infection or LBW (9). IFN- production by inter-
villous blood cells was associated with protection from malaria
in pregnancy in multigravid women (16), and impaired IFN-
production was mooted as a cause for the increased suscepti-
bility of HIV-infected women to placental malaria (17). We
found that although malaria-infected placentas had higher
IFN- levels than did uninfected placentas, these levels were
generally extremely low. HIV infection was associated with
higher IFN- levels among women without malaria, consistent
with the placental immune activation reported in HIV infec-
tion (14). Moorman et al. found no detectable IFN- or IL-12
mRNA in placental biopsy specimens from primigravid
Malawian women (18), while IL-12 production was frequent in
peripheral blood mononuclear cells from non-HIV-infected
Kenyan women (5). IL-12 plays a key role in induction of
IFN- production and appears to protect against malaria in-
fection and anemia in mice (29). Differences in host response
to placental malaria may have a genetic basis (20), as has
recently been proposed for severe anemia (10).
Increases in placental TNF- levels are associated with pla-
cental malaria and LBW. Whether cytokine production causes
impaired fetal growth or is a marker of other processes result-
ing in poor pregnancy outcome requires further study.
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